Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones2024-12-31

DJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 2.30% to $399.35 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.07% to 5,906.94 and Dow Jones Industrial Average falling 0.97% to 42,573.73.

This was the stock's second consecutive day of losses.

Vertex Pharmaceuticals Inc. closed $120.53 below its 52-week high ($519.88), which the company reached on November 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ fell 1.02% to $176.20, Krystal Biotech Inc. (KRYS) rose 0.32% to $159.80, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 2.59% to $16.58.

Data source: Dow Jones Market Data, FactSet. Data compiled December 30, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 30, 2024 16:42 ET (21:42 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2495798505?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-31 05:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495798505","market":"sh","top_or_hot":-1,"title":"Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Vertex Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VRTX\">$(VRTX)$</a> shed 2.30% to $399.35 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index  falling 1.07% to 5,906.94 and Dow Jones Industrial Average  falling 0.97% to 42,573.73. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Vertex Pharmaceuticals Inc. closed $120.53 below its 52-week high ($519.88), which the company reached on November 8th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> fell 1.02% to $176.20, <a href=\"https://laohu8.com/S/KRYS\">Krystal Biotech Inc.</a> (KRYS) rose 0.32% to $159.80, and Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Holdings Inc. <a href=\"https://laohu8.com/S/ARCT\">$(ARCT)$</a> fell 2.59% to $16.58. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 30, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 30, 2024 16:42 ET (21:42 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-31 05:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRTX","symbol_name":"福泰制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2495798505","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495798505","pubTimestamp":1735594920,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Vertex Pharmaceuticals Inc.  shed 2.30% to $399.35 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.07% to 5,906.94 and Dow Jones Industrial Average  falling 0.97% to 42,573.73.This was the stock's second consecutive day of losses.Vertex Pharmaceuticals Inc. closed $120.53 below its 52-week high , which the company reached on November 8th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc.  fell 1.02% to $176.20, Krystal Biotech Inc.  rose 0.32% to $159.80, and Arcturus Therapeutics Holdings Inc.  fell 2.59% to $16.58.Data source: Dow Jones Market Data, FactSet. Data compiled December 30, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Jo","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"VRTX":"福泰制药","VERX":"Vertex, Inc."},"translate_title":"与竞争对手相比，Vertex Pharmaceuticals Inc.股票周一表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERX":1,"VRTX":1},"content_text":"DJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 2.30% to $399.35 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.07% to 5,906.94 and Dow Jones Industrial Average  falling 0.97% to 42,573.73. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Vertex Pharmaceuticals Inc. closed $120.53 below its 52-week high ($519.88), which the company reached on November 8th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ fell 1.02% to $176.20, Krystal Biotech Inc. (KRYS) rose 0.32% to $159.80, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 2.59% to $16.58. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 30, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 30, 2024 16:42 ET (21:42 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2495798505"}